Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8750
-0.0650 (-6.91%)
At close: Jul 30, 2025, 4:00 PM
0.8750
0.00 (0.00%)
After-hours: Jul 30, 2025, 6:14 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $31.64 million as of July 30, 2025. Its market cap has decreased by -38.74% in one year.
Market Cap
31.64M
Enterprise Value
31.23M
1-Year Change
-38.74%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $31.64M, an increase of 1,680.20%. That is a compound annual growth rate of 181.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 34.00M | -21.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.47B |
| Johnson & Johnson | 400.31B |
| AbbVie | 333.00B |
| Novo Nordisk | 311.87B |
| UnitedHealth Group | 255.92B |
| Novartis AG | 225.40B |
| AstraZeneca | 224.29B |
| Abbott Laboratories | 219.83B |